{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T23:18:28Z","timestamp":1793488708312,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,11,27]],"date-time":"2012-11-27T00:00:00Z","timestamp":1353974400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s00296-012-2580-4","type":"journal-article","created":{"date-parts":[[2012,11,26]],"date-time":"2012-11-26T12:58:21Z","timestamp":1353934701000},"page":"1475-1480","source":"Crossref","is-referenced-by-count":49,"title":["Clinical characteristics and prognostic factors for relapse in patients with polymyalgia rheumatica (PMR)"],"prefix":"10.1007","volume":"33","author":[{"given":"Jung Hwa","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Tae","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Su","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo Young","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Ki","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Sook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Sung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Soo","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Heon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae-Rim","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,27]]},"reference":[{"key":"2580_CR1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1056\/NEJMra011913","volume":"347","author":"C Salvarani","year":"2002","unstructured":"Salvarani C, Cantini F, Boiardi L, Hunder GG (2002) Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 347:261\u2013271","journal-title":"N Engl J Med"},{"key":"2580_CR2","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1517\/14656561003724739","volume":"11","author":"MA Gonzalez-Gay","year":"2010","unstructured":"Gonzalez-Gay MA, Agudo M, Martinez-Dubois C, Pompei O, Blanco R (2010) Medical management of polymyalgia rheumatica. Expert Opin Pharmacother 11:1077\u20131087","journal-title":"Expert Opin Pharmacother"},{"key":"2580_CR3","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1136\/ard.2003.011379","volume":"63","author":"BF Leeb","year":"2004","unstructured":"Leeb BF, Bird HA (2004) A disease activity score for polymyalgia rheumatica. Ann Rheum Dis 63:1279\u20131283","journal-title":"Ann Rheum Dis"},{"key":"2580_CR4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/art.23176","volume":"58","author":"RC Lawrence","year":"2008","unstructured":"Lawrence RC, Felson DT, Helmick CG et al (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 58:26\u201335","journal-title":"Arthritis Rheum"},{"key":"2580_CR5","first-page":"270","volume":"35","author":"B Dasgupta","year":"2008","unstructured":"Dasgupta B, Salvarani C, Schirmer M et al (2008) Developing classification criteria for polymyalgia rheumatica: comparison of views from an expert panel and wider survey. J Rheumatol 35:270\u2013277","journal-title":"J Rheumatol"},{"key":"2580_CR6","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1136\/ard.2004.025296","volume":"64","author":"HA Bird","year":"2005","unstructured":"Bird HA, Leeb BF, Montecucco CM et al (2005) A comparison of the sensitivity of diagnostic criteria for polymyalgia rheumatica. Ann Rheum Dis 64:626\u2013629","journal-title":"Ann Rheum Dis"},{"key":"2580_CR7","first-page":"130","volume":"25","author":"B Dasgupta","year":"2007","unstructured":"Dasgupta B, Matteson EL, Maradit-Kremers H (2007) Management guidelines and outcome measures in polymyalgia rheumatica (PMR). Clin Exp Rheumatol 25:130\u2013136","journal-title":"Clin Exp Rheumatol"},{"key":"2580_CR8","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1093\/rheumatology\/kep303a","volume":"49","author":"B Dasgupta","year":"2010","unstructured":"Dasgupta B, Borg FA, Hassan N et al (2010) BSR and BHPR guidelines for the management of polymyalgia rheumatica. Rheumatology (Oxford) 49:186\u2013190","journal-title":"Rheumatology (Oxford)"},{"key":"2580_CR9","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1002\/1529-0131(199807)41:7<1221::AID-ART12>3.0.CO;2-W","volume":"41","author":"C Salvarani","year":"1998","unstructured":"Salvarani C, Cantini F, Macchioni P et al (1998) Distal musculoskeletal manifestations in polymyalgia rheumatica: a prospective followup study. Arthritis Rheum 41:1221\u20131226","journal-title":"Arthritis Rheum"},{"key":"2580_CR10","first-page":"2179","volume":"27","author":"MA Gonzalez-Gay","year":"2000","unstructured":"Gonzalez-Gay MA, Garcia-Porrua C, Salvarani C, Olivieri I, Hunder GG (2000) The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain. J Rheumatol 27:2179\u20132184","journal-title":"J Rheumatol"},{"key":"2580_CR11","first-page":"65","volume":"32","author":"HM Kremers","year":"2005","unstructured":"Kremers HM, Reinalda MS, Crowson CS, Zinsmeister AR, Hunder GG, Gabriel SE (2005) Relapse in a population based cohort of patients with polymyalgia rheumatica. J Rheumatol 32:65\u201373","journal-title":"J Rheumatol"},{"key":"2580_CR12","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1002\/art.1780261007","volume":"26","author":"CA Smith","year":"1983","unstructured":"Smith CA, Fidler WJ, Pinals RS (1983) The epidemiology of giant cell arteritis. Report of a ten-year study in Shelby County Tennessee. Arthritis Rheum 26:1214\u20131219","journal-title":"Arthritis Rheum"},{"key":"2580_CR13","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1136\/ard.38.5.434","volume":"38","author":"HA Bird","year":"1979","unstructured":"Bird HA, Esselinckx W, Dixon AS, Mowat AG, Wood PH (1979) An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 38:434\u2013439","journal-title":"Ann Rheum Dis"},{"key":"2580_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3949\/ccjm.52.2.155","volume":"52","author":"WS Wilke","year":"1985","unstructured":"Wilke WS, Wysenbeek AJ, Krall PL, Segal AM (1985) Masked presentation of giant-cell arteritis. Cleve Clin Q 52:155\u2013159","journal-title":"Cleve Clin Q"},{"key":"2580_CR15","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1093\/rheumatology\/35.11.1161","volume":"35","author":"G Myklebust","year":"1996","unstructured":"Myklebust G, Gran JT (1996) A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol 35:1161\u20131168","journal-title":"Br J Rheumatol"},{"key":"2580_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/art.20901","volume":"53","author":"C Salvarani","year":"2005","unstructured":"Salvarani C, Cantini F, Niccoli L et al (2005) Acute-phase reactants and the risk of relapse\/recurrence in polymyalgia rheumatica: a prospective followup study. Arthritis Rheum 53:33\u201338","journal-title":"Arthritis Rheum"},{"key":"2580_CR17","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1136\/ard.52.12.847","volume":"52","author":"V Kyle","year":"1993","unstructured":"Kyle V, Hazleman BL (1993) The clinical and laboratory course of polymyalgia rheumatica\/giant cell arteritis after the first two months of treatment. Ann Rheum Dis 52:847\u2013850","journal-title":"Ann Rheum Dis"},{"key":"2580_CR18","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/art.22777","volume":"57","author":"A Hutchings","year":"2007","unstructured":"Hutchings A, Hollywood J, Lamping DL et al (2007) Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumatica. Arthritis Rheum 57:803\u2013809","journal-title":"Arthritis Rheum"},{"key":"2580_CR19","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1093\/rheumatology\/kep395","volume":"49","author":"SL Mackie","year":"2010","unstructured":"Mackie SL, Hensor EM, Haugeberg G, Bhakta B, Pease CT (2010) Can the prognosis of polymyalgia rheumatica be predicted at disease onset? Results from a 5-year prospective study. Rheumatology (Oxford) 49:716\u2013722","journal-title":"Rheumatology (Oxford)"},{"key":"2580_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10067-010-1619-8","volume":"30","author":"P Ornetti","year":"2011","unstructured":"Ornetti P, Guillibert-Karras C, Garrot JF et al (2011) Study of professional practices among rheumatologists in Burgundy: initial corticotherapy in polymyalgia rheumatica. Clin Rheumatol 30:51\u201356","journal-title":"Clin Rheumatol"},{"key":"2580_CR21","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1001\/archinternmed.2009.352","volume":"169","author":"J Hernandez-Rodriguez","year":"2009","unstructured":"Hernandez-Rodriguez J, Cid MC, Lopez-Soto A, Espigol-Frigole G, Bosch X (2009) Treatment of polymyalgia rheumatica: a systematic review. Arch Intern Med 169:1839\u20131850","journal-title":"Arch Intern Med"},{"key":"2580_CR22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1196\/annals.1351.030","volume":"1069","author":"MA Cimmino","year":"2006","unstructured":"Cimmino MA, Parodi M, Caporali R, Montecucco C (2006) Is the course of steroid-treated polymyalgia rheumatica more severe in women? Ann N Y Acad Sci 1069:315\u2013321","journal-title":"Ann N Y Acad Sci"},{"key":"2580_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1053\/sarh.2000.8366","volume":"30","author":"F Cantini","year":"2000","unstructured":"Cantini F, Salvarani C, Olivieri I et al (2000) Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study. Semin Arthritis Rheum 30:17\u201324","journal-title":"Semin Arthritis Rheum"},{"key":"2580_CR24","doi-asserted-by":"publisher","first-page":"493","DOI":"10.7326\/0003-4819-141-7-200410050-00005","volume":"141","author":"R Caporali","year":"2004","unstructured":"Caporali R, Cimmino MA, Ferraccioli G et al (2004) Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 141:493\u2013500","journal-title":"Ann Intern Med"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2580-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-012-2580-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2580-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2580-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T13:27:19Z","timestamp":1562678839000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-012-2580-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,27]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["2580"],"URL":"https:\/\/doi.org\/10.1007\/s00296-012-2580-4","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,27]]}}}